Bandaríkin - enska - NLM (National Library of Medicine)

redpharm drug, inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570) - oxycodone hydrochloride 10 mg - oxycodone hcl extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate in: • adults; and • opioid-tolerant pediatric patients 11 years of age and older who are already receiving and tolerate a minimum daily opioid dose of at least 20 mg oxycodone orally or its equivalent. limitations of use • because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see warnings and precautions (5.1)], reserve oxycodone hcl extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. • oxycodone hcl extended-release tablets are not indic

Bandaríkin - enska - NLM (National Library of Medicine)

st. mary's medical park pharmacy - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 5 mg - oxycodone and acetaminophen tablets are indicated for the management of  pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ] , reserve oxycodone and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia oxycodone  and acetaminophen tablets are contraindicated in patients with:  - significant respiratory depression [see warnings ] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings ] - hypersensitivity to

Kanada - enska - Health Canada

pharmascience inc - oxycodone hydrochloride - tablet - 5mg - oxycodone hydrochloride 5mg - opiate agonists

Kanada - enska - Health Canada

pharmascience inc - oxycodone hydrochloride - tablet - 10mg - oxycodone hydrochloride 10mg - opiate agonists

Kanada - enska - Health Canada

pharmascience inc - oxycodone hydrochloride - tablet - 20mg - oxycodone hydrochloride 20mg - opiate agonists

Kanada - enska - Health Canada

laboratoire riva inc. - oxycodone hydrochloride - tablet (extended-release) - 10mg - oxycodone hydrochloride 10mg - opiate agonists

Kanada - enska - Health Canada

laboratoire riva inc. - oxycodone hydrochloride - tablet (extended-release) - 20mg - oxycodone hydrochloride 20mg - opiate agonists

Kanada - enska - Health Canada

laboratoire riva inc. - oxycodone hydrochloride - tablet (extended-release) - 40mg - oxycodone hydrochloride 40mg - opiate agonists

Kanada - enska - Health Canada

laboratoire riva inc. - oxycodone hydrochloride - tablet (extended-release) - 80mg - oxycodone hydrochloride 80mg - opiate agonists

Bandaríkin - enska - NLM (National Library of Medicine)

actavis pharma, inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - oxycodone hydrochloride 4.8355 mg - oxycodone and aspirin tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses (see warnings), reserve oxycodone and aspirin tablets for use in patients for whom alternative treatment options (e.g., non- opioid analgesics) - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia oxycodone and aspirin tablets are contraindicated in patients with: - significant respiratory depression (see warnings) - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment (see warnings) - known or suspected gastrointestinal obstruction, including paralytic ileus (see warnings) - hypersensitivity to oxycodone or aspirin, (e.g. angioedema) (see warnings) - patients with hemophilia. - aspi